Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study

著者: Léa Hoisnard, Laura Pina Vegas, Rosemary Dray‐Spira, Alain Weill, Mahmoud Zureik, É. Sbidian - Annals of the Rheumatic Diseases 2022 被引用: 118